🇺🇸 FDA
Patent

US 9932322

Method for producing sulfonyl chloride compound

granted A61KA61K9/2018A61K9/2866

Quick answer

US patent 9932322 (Method for producing sulfonyl chloride compound) held by Takeda Pharmaceutical Company Limited expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K9/2018, A61K9/2866